The U.S. knee replacement market is expected to witness significant growth in the coming years due to the rising prevalence of knee-related diseases and increasing elderly population in the country. Technological advancements in knee replacement surgeries and growing awareness about the benefits of knee replacement procedures are also driving the market growth.
Two growth drivers for the U.S. knee replacement market include the increasing adoption of minimally invasive surgical techniques for knee replacement procedures and the rising healthcare expenditure in the country. These factors are expected to boost the demand for knee replacement surgeries and contribute to market growth.
Segment Analysis:
The U.S. knee replacement market can be segmented by type of procedure (total knee replacement, partial knee replacement, and revision knee replacement), implant material (metal, ceramic, and plastic), and end-user (hospitals, ambulatory surgical centers, and specialty clinics). Each segment has its own market dynamics and growth opportunities, contributing to the overall market outlook.
Competitive Landscape:
Key players in the U.S. knee replacement market include Zimmer Biomet Holdings Inc., Stryker Corporation, Smith & Nephew plc, Johnson & Johnson, and Medtronic plc, among others. These companies are focusing on product innovation, strategic collaborations, and mergers and acquisitions to maintain their market position and gain a competitive edge. The increasing competition among market players is expected to drive market growth and offer more choices to consumers in the coming years.